Edinburgh, United Kingdom

Kenneth Andrew Rose

This inventor holds 3 USPTO granted patents. Top assignees: Btg International Limited, The University of Edinburgh. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Andrew Rose. Retrieved from https://idiyas.com/inventor/kenneth-andrew-rose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth Andrew Rose

Introduction

Kenneth Andrew Rose is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropsychiatric, immune, and endocrine disorders. With a total of three patents to his name, Rose's work has the potential to impact various medical applications.

Latest Patents

One of Kenneth Andrew Rose's latest patents focuses on the use of 7 α-substituted steroids to treat neuropsychiatric, immune, or endocrine disorders. This invention provides a method for utilizing a 7α-hydroxy or 7-oxo substituted 3β-hydroxy-steroid, which possesses the carbon skeleton of cholesterol, androsterone, pregnenolone, or estradiol. The patent outlines the manufacture of a pharmaceutical composition aimed at therapy for these disorders or for inducing cognitive enhancement. Additionally, it discusses the use of Cyp7b enzymes in producing such steroids, along with various novel steroids and diagnostic test kits.

Another significant patent by Rose involves hippocampus-associated proteins and the DNA sequences coding for them. This invention presents novel hippocampus-associated proteins identified through differential screening of a rat hippocampus cDNA library. A cDNA species encoding a novel protein designated Hct-1 was isolated, which is related to cytochromes P450. The use of hybridization probes based on the rat Hct-1 sequence has facilitated the identification of homologues in other mammalian species.

Career Highlights

Throughout his career, Kenneth Andrew Rose has worked with reputable organizations, including Btg International Limited and the University of Edinburgh. His experience in these institutions has contributed to his innovative research and development in the pharmaceutical field.

Collaborations

Rose has collaborated with notable individuals such as Richard Lathe and Genevieve Stapleton. These partnerships have likely enhanced his research efforts and broadened the scope of his inventions.

Conclusion

Kenneth Andrew Rose's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in the treatment of various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…